Phase 1 cystic fibrosis trial studying novel enzyme replacement therapy in adults
Patients 18 years of age and older with cystic fibrosis now have an option of participating in a Phase 1 trial of a novel, broad-spectrum, orally delivered enzyme replacement therapy for cystic fibrosis (CF). The [...]
View more
Sciatic neuropathy case study: 4-centimeter tumor discovered on sciatic nerve
The patient A 64-year-old woman tripped after “missing a step,” fracturing her left tibial plateau and resulting in deformity of the joint. This was managed conservatively, with a leg brace removing weight from the extremity. [...]
View more
March 2024 Norton Medical Group new providers
Paul A. Kniery, M.D. Internal Medicine Stephen Love, M.D. Behavioral Medicine Sarah A. Mayfield, M.D. Internal Medicine Emmanuel A. Nidhiry, M.D. Medical Oncology and Hematology Anupama Raghuram, M.D. Infectious Diseases Elizabeth Fahey, PA-C Hand Surgery […]
View more
Updated information on lecanemab infusions for mild cognitive impairment and Alzheimer’s
In 2023, the Food and Drug Administration (FDA) approved lecanemab (brand name Leqembi) for the treatment of Alzheimer’s disease. Lecanemab is the first widely used medication in a new class of anti-amyloid agents for the […]
View more
Norton Louisville Arm & Hand becomes Norton Arm & Hand Institute
Norton Arm & Hand Institute is the new name for Norton Louisville Arm & Hand, as of March 1, 2024. The goal of Norton Arm & Hand Institute is to be a destination program by […]
View more
Open-access, peer-reviewed medical journal accepting submissions
Norton Healthcare has launched a new, open-access medical journal to promote the sharing of innovation and ideas from the laboratory, the bedside and everyday practice. Norton Healthcare Medical Journal welcomes original articles related to medicine, […]
View more
Antimicrobial stewardship
The Norton Healthcare Antimicrobial Stewardship Program was recognized this year as the first and only antimicrobial stewardship center of excellence in the United States by the British Society of Antimicrobial Chemotherapy. The international collaboration is […]
View more
Norton Cancer Institute enrolling patients for gotistobart (ONC-392) Phase 3 trial
Norton Cancer Institute is enrolling metastatic lung cancer patients in a Phase 3 clinical trial to test a promising new anti-CLTA-4 antibody, gotistobart (ONC-392). The study will test whether gotistobart is more effective than the [...]
View more
Christopher P. Rhyne, M.D., headache medicine specialist, has joined Norton Neuroscience Institute
Christopher P. Rhyne, M.D., is a headache medicine specialist at Norton Neuroscience Institute. He earned his medical degree from Windsor University School of Medicine, St. Kitts, West Indies. He completed his residency in family medicine […]
View more
February 2024 Norton Medical Group new providers
Scott M. McClain, M.D. Emergency Medicine Stephen R. Roszell, M.D. Urgent Care Jerome J. Tuitt, M.D. Hospital Medicine Shengnan Zheng, M.D. Hospital Medicine Timothy J. Ziolkowski, M.D. Emergency Medicine Katharine Adelstein, APRN Psycho-oncology Lunden A. […]
View more
Louisville Business First has recognized Norton Healthcare and Norton Children’s research team members with its 2024 Health Care Heroes Innovator Award
Louisville Business First has recognized researchers at Norton Healthcare with its 2024 Health Care Heroes Innovator Award. The award honors those who break ground in the health care field by developing or implementing new technology, [...]
View more
How evidence-based “exercise snacks” can combat sedentary lifestyles
What are “exercise snacks”? A newer concept for evidence-based exercises, called “exercise snacks” or “activity snacks,” is gaining traction for helping improve health outcomes for patients with sedentary lifestyles. These “snacks,” which involve short bursts […]
View more